A Runaway Hit In US, Pfizer Gains EU Nod for Vyndaqel In Cardiomyopathy
Company Considers Using AI To Boost Diagnoses
Vydaqel saw its uptake take off in the US last year. UK’s NICE to pass judgement on cost effectiveness by June.
You may also be interested in...
The Swiss firm that discovered Biogen’s Alzheimer’s therapy aducanumab has built a pipeline of clinical programs across neurological and other diseases and may seek additional partners as candidates advance.
Its ‘virus chasing’ habits has given Inovio a bad reputation. But with backing from CEPI and Bill Gates, it has a chance to prove the doubters wrong.
Investment from Janssen helps to validate the platform developed by the San Diego-based company.